Media MICE

09/10/2025

From the Raffles Bar to the OR, Prof. Jodbhir Mehta’s “Singapore Sling” isn’t just a cocktail, it’s a clever surgical move.

At APACRS 2025, he showed how the Teleon FEMTIS® IOL can be anchored securely on the anterior capsule to handle posterior capsule rupture, delivering premium outcomes, stable fixation and no negative dysphotopsia. It’s a case study that blends surgical creativity with crisp visual results.

More info at: https://www.teleon-surgical.com

This content is intended exclusively for healthcare professionals and eye care practitioners. It is not intended for the general public. Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore.

APACRS - Asia-Pacific Association of Cataract & Refractive Surgeons

08/10/2025

What do a boat on the Seine and Dr. Roger Goldberg have in common? Both made serious waves at this year’s EURETINA

Media MICE’s Matt Young joined Dr. Goldberg for a cruise through the latest currents in retina, from AI and gene therapy to next-gen drug delivery and healthcare from the eye.

So grab your funky jacket (if you have one) and hop on board (virtually at least)—the future of retina care just set sail.

Watch the full conversation and get more on-the-ground expert takes here: https://www.youtube.com/.

This content is intended exclusively for healthcare professionals and eye care practitioners. It is not intended for the general public. Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore.

08/10/2025

“LuxSmart™ has already fitted into my practice beautifully—and it’s my go-to lens now,” says Dr. Kamal B. Kapur (India). With more than 4,000 implants and patient satisfaction as supporting evidence, he reveals how Bausch + Lomb’s LuxSmart™ EDOF lens delivers smooth optics, no halos and reliable stability. Real-world outcomes show why modern patients prefer it for both near and distance vision. Hear his experience, his data and his insights straight from practice.

Learn more at https://www.bausch.com/.

This content is intended exclusively for healthcare professionals and eye care practitioners. It is not intended for the general public. Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore.

07/10/2025

This one’s for the retinal rockstars navigating comorbid chaos, systemic curveballs and patients who just won’t show up for their next anti-VEGF. PIE 36 is officially on your OCT screen and it’s our Comorbidities Issue. Read the full issue here https://issuu.com/mediamice/docs/pie_issue_36_-_the_comorbidities_issue?fr=sYTVmZTg3MjA5MTk

Inside, you’ll find eye-opening stories that prove the back of the eye sees a lot more than just the retina:

–In “The Eye as Atlas,” retina specialists and AI researchers chart how our favorite light-sensing organ moonlights as a full-body diagnostic map. Forget palm reading… try fundus forecasting.

–“The Adherence Equation” crunches the global numbers from 10,000 patients and doctors to solve one of retinal care’s hardest riddles: how to make patients stick with treatment before vision slips away.

–“When Less is More” explores hydrogel-based drug delivery systems that aim to space out anti-VEGF injections. Because sometimes fewer pokes mean more progress.

–“Quieting the PVR Storm” takes on one of vitreoretina’s trickiest customers: proliferative vitreoretinopathy. Think methotrexate, molecular profiling and some seriously futuristic fire extinguishers.

– And in “From Degeneration to Regeneration,” the dry AMD pipeline gets an upgrade from slowing the slide to wild new cell and gene approaches designed to bring vision back from the brink.
Kudos to all the newsmakers featured in PIE 36: the retinal rebels, data-driven thinkers and precision pioneers keeping the posterior segment sharp.

This content is intended exclusively for healthcare professionals and eye care practitioners. It is not intended for the general public. Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore.

Welcome to Issuu’s blog: home to product news, tips, resources, interviews (and more) related to content marketing and publishing.

07/10/2025

Red, itchy eyelids. Fluctuating vision. Contact lens intolerance. Persistent inflammation..
Sometimes the culprit isn’t what you think.

In the latest video in our Demodex blepharitis series, Dr. Radhika Rampat highlights how mite-induced inflammation can mimic dry eye, MGD or ocular allergies, and how spotting collarettes through the slit lamp exam, can reframe your whole diagnostic approach.

Collarettes tell the tale. Look at the lids. Join the Collarette Community https://lookatthelids.eu/join-the-collarette-community/

Dr. Radhika Rampat is a paid consultant of Tarsus Pharmaceuticals, Inc.



GL--2500119 9/25

06/10/2025

For years, MIGS wasn’t considered a viable treatment option for patients with severe glaucoma—but a retrospective study from Dr. Shamil Patel (United States) is rewriting the narrative. He used iTrack™ Advance Canaloplasty in a 3-year study covering 72 eyes across all glaucoma stages and found something remarkable: it worked for all of them. Whether early-stage or advanced, canaloplasty was able to restore the eye’s natural drainage, lower IOP and reduce the medication burden. Explore the data that supports the role of canaloplasty across the full spectrum of glaucoma. Watch now.

This content is intended exclusively for healthcare professionals and eye care practitioners. It is not intended for the general public. Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore.

Nova Eye Medical

06/10/2025

When the slit lamp was invented in 1911, it changed the way we saw the eye. The Elara 900 changes how we show it.

Prof. Maria Kugelberg (Sweden) shares why this fully integrated, ergonomic, imaging-first reinvention is winning over everyone from seniors and residents to patients and their families. By capturing and sharing findings in real time, it turns innovation into collaboration.

Learn more about the Elara 900: https://haag-streit.com/en/Campaigns/elara/900

This content is intended exclusively for healthcare professionals and eye care practitioners. It is not intended for the general public. Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore.

Haag-Streit

03/10/2025

Dr. Soosan Jacob showed that keratoconus care can be reshaped in seconds.

Her new twist on CAIRS—the customized trephine-cut technique—lets surgeons cut precision segments in under 15 seconds, tailored to the unique steepness of each cornea. The result is sharper optics, stronger biomechanics and smoother integration with cross-linking.

For surgeons, it’s surgery with a sharper edge.

Subscribe to MICE TV: https://www.youtube.com/

This content is intended exclusively for healthcare professionals and eye care practitioners. It is not intended for the general public. Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore.

03/10/2025

When thick glasses won’t cut it, precision optics steps in.

At APACRS 2025, Dr. Benjamin Cabrera shares how a customized toric multifocal from Teleon helped one high-myopic patient ditch the coke-bottle lenses to game in style. With 20/16 post-op visual acuity in both eyes, FLACS and a tailored Mplus solution made all the difference.

Full cocktail recipe for refractive success here: https://www.teleon-surgical.com

This content is intended exclusively for healthcare professionals and eye care practitioners. It is not intended for the general public. Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore.

APACRS - Asia-Pacific Association of Cataract & Refractive Surgeons

02/10/2025

Surf’s up in Copenhagen! At ESCRS 2025, SIFI SpA's wavefront-driven IOLs had surgeons swapping data like surfers comparing perfect breaks.

Prof. Ribeiro, Dr. Savini, Prof. Assaf, Prof. Mazzini, Dr. Gabrić and Dr. Mertens took the stage to share how surgeons could confidently select the right SIFI IOL for each patient's needs.
Hop on board and read the full recap: https://cakemagazine.org/riding-the-wavefront-of-innovation-with-iols-from-sifi/

This content is intended exclusively for healthcare professionals and eye care practitioners. It is not intended for the general public. Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore.

The European Society of Cataract and Refractive Surgeons (ESCRS)

01/10/2025

Glaucoma care that’s more than just IOP, Finland’s secret weapon against myopia and some regulatory déjà vu in wet AMD. This month’s SightByte News is serving up stories shaking the eye care world:

-Glaucoma care beyond the slit lamp. Why empathy, equity and maybe a little hand-holding matter as much as IOP. Read more: https://cakemagazine.org/quality-treatment-newly-diagnosed-glaucoma-patients/

-Wet AMD FDA drama. Outlook Therapeutics takes another shot at approval for ONS-5010. Read more: https://piemagazine.org/outlook-therapeutics-seeks-meeting-fda-wet-amd/

-Radiation maculopathy recognized. Roca’s RCT002 scores the first-ever EMA Orphan Drug Designation. Read more: https://piemagazine.org/roca-therapeutics-ema-radiation-maculopathy/

-Finland’s myopia mystery. Low prevalence, less cramming and more sunshine. Could lifestyle trump genetics? Read more: https://cookiemagazine.org/myopia-prevalence-finnish-conscripts-research/

-Mental health meets the eye. Topcon backs Senseye to screen PTSD, anxiety and other mental health issues with ocular biomarkers. Read more: https://cakemagazine.org/topcon-investment-senseye-mental-health-ophthalmology/

Subscribe for more bite-sized brilliance from the world of eye care, only on SightByte News by MICE TV. Got a juicy story or a hot take? Drop it in the comments!

This content is intended exclusively for healthcare professionals and eye care practitioners. It is not intended for the general public. Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore.

01/10/2025

Eye health is essential—but access isn’t equal for everyone. This World Sight Day, join the International Agency for the Prevention of Blindness (IAPB) in championing equity in global eye care. Schedule an eye exam today and share the message that sight is a gift everyone deserves. Change begins with you. And that change grows as you help others see a brighter future too.

Explore ways to get more involved with the campaign. https://brnw.ch/21wUpHc

VISION 2020/IAPB